Immunogenetics pp 267-277 | Cite as

Impact of HLA Matching and HLA Antibodies in Organ Transplantation: A Collaborative Transplant Study View

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 882)

Abstract

The Collaborative Transplant Study (CTS) was initiated in 1982 in Heidelberg, Germany, and originated from the need to gain further insight into the complex problems and risks involved in human organ transplantation. Currently, more than 400 transplant centers in 45 countries are contributing to this voluntary international effort, and from the beginning of the study, the impact on graft outcome of immunological factors, such as matching for HLA antigens and allosensitization to HLA and non-HLA antigens, have been areas of interest. Herein, we summarize the recent findings from the CTS on these two topics.

Key words

HLA matching HLA antibodies Crossmatch Kidney transplantation Liver transplantation Heart transplantation 

References

  1. 1.
    Mange KC et al (2001) A comparison of the survival of shipped and locally transplanted cadaveric renal allografts. N Engl J Med 345:1237–1242PubMedCrossRefGoogle Scholar
  2. 2.
    Collaborative Transplant Study, University of Heidelberg, Germany, Website. www.ctstransplant.org. Accessed 29 Nov 2010
  3. 3.
    Opelz G, Döhler B (2007) Multicenter analysis of kidney preservation. Transplantation 83:247–253PubMedCrossRefGoogle Scholar
  4. 4.
    Opelz G, Döhler B (2007) Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 84:137–143PubMedCrossRefGoogle Scholar
  5. 5.
    Opelz G, Döhler B (2010) Impact of HLA mismatching on incidence of posttransplant non-Hodgkin lymphoma after kidney transplantation. Transplantation 89:567–572PubMedCrossRefGoogle Scholar
  6. 6.
    Opelz G, Döhler B (2010) Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. Transplantation 91:65–69CrossRefGoogle Scholar
  7. 7.
    Meier-Kriesche HU et al (2009) A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 88:23–29PubMedCrossRefGoogle Scholar
  8. 8.
    Opelz G et al (2010) Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report. Transplantation 90:912–927PubMedCrossRefGoogle Scholar
  9. 9.
    Opelz G, Döhler B (2010) Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 90:292–297PubMedCrossRefGoogle Scholar
  10. 10.
    Nikkel LE et al (2009) Risk of fractures after renal transplantation in the United States. Transplantation 87:1846–1851PubMedCrossRefGoogle Scholar
  11. 11.
    O’Shaughnessy EA et al (2002) Risk factors for fractures in kidney transplantation. Transplantation 74:362–366PubMedCrossRefGoogle Scholar
  12. 12.
    Vautour LM et al (2004) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160–167PubMedCrossRefGoogle Scholar
  13. 13.
    Patel S et al (2001) Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863–1870PubMedCrossRefGoogle Scholar
  14. 14.
    Opelz G et al (1999) HLA compatibility and organ transplant survival. Collaborative Trans-plant Study. Rev Immunogenet 1:334–342PubMedGoogle Scholar
  15. 15.
    Süsal C, Pelzl S, Opelz G (2003) Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30. Transplantation 76:1231–1232PubMedCrossRefGoogle Scholar
  16. 16.
    Süsal C, Döhler B, Opelz G (2009) Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 70:569–573PubMedCrossRefGoogle Scholar
  17. 17.
    Opelz G et al (1981) Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 32:177–183PubMedCrossRefGoogle Scholar
  18. 18.
    El-Awar N et al (2002) Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplant Proc 34:2531–2532PubMedCrossRefGoogle Scholar
  19. 19.
    Opelz G, Collaborative Transplant Study (2005) Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365:1570–1576PubMedCrossRefGoogle Scholar
  20. 20.
    Zou Y et al (2006) Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 67:230–237PubMedCrossRefGoogle Scholar
  21. 21.
    Terasaki PI, Ozawa M (2005) Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 80:1194–1197PubMedCrossRefGoogle Scholar
  22. 22.
    Breimer ME et al (2009) Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 87:549–556PubMedCrossRefGoogle Scholar
  23. 23.
    Reinsmoen NL et al (2010) Anti-angiotensin type 1 receptor antibodies associated with ­antibody mediated rejection in donor HLA antibody negative patients. Transplantation 90:1473–1477PubMedCrossRefGoogle Scholar
  24. 24.
    Morath C et al (2010) An integrative approach for the transplantation of high-risk sensitized patients. Transplantation 90:645–653PubMedCrossRefGoogle Scholar
  25. 25.
    Fuggle SV, Martin S (2008) Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 86:384–390PubMedCrossRefGoogle Scholar
  26. 26.
    Süsal C, Döhler B, Opelz G (2009) Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 70:569–573PubMedCrossRefGoogle Scholar
  27. 27.
    Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735–739PubMedCrossRefGoogle Scholar
  28. 28.
    Opelz G, Döhler B, Süsal C (2009) Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Hum Immunol 70:627–630PubMedCrossRefGoogle Scholar
  29. 29.
    Bingaman AW et al (2008) A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 86:1864–1868PubMedCrossRefGoogle Scholar
  30. 30.
    Ettenger RB et al (1979) Long-term cadaver allograft survival in the recipient with a positive B lymphocyte crossmatch. Transplantation 27:315–318PubMedCrossRefGoogle Scholar
  31. 31.
    Hourmant M et al (1990) Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one center study. Clin Transpl 301–309Google Scholar
  32. 32.
    Bryan CF et al (2007) Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transpl 21:72–79CrossRefGoogle Scholar
  33. 33.
    Magee CC et al (2008) Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center’s experience. Transplantation 86:96–103PubMedCrossRefGoogle Scholar
  34. 34.
    Kerman RH et al (1990) Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients. Transplantation 49:52–56PubMedCrossRefGoogle Scholar
  35. 35.
    Christiaans MH et al (1996) No advantage of flow cytometry crossmatch over complement dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 62:1341–1347PubMedCrossRefGoogle Scholar
  36. 36.
    Swinnen LJ et al (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723–1728PubMedCrossRefGoogle Scholar
  37. 37.
    Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514–1516PubMedCrossRefGoogle Scholar
  38. 38.
    Opelz G, Döhler B (2004) Lymphomas after solid organ transplantation: a Collaborative Transplant Study report. Am J Transplant 24:222–230CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Transplantation Immunology, Institute of ImmunologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations